Skip to content
Themes / Healthcare & Hospitals

Healthcare & Hospitals

Hospitals, diagnostics, healthcare services, and medical tourism.

HealthcareAuto-built
Theme price path

Healthcare & Hospitals vs Nifty 500

Weekly basket performance over the latest 26 observations. Green is ahead of Nifty 500; red is behind.

Through 22 Oct 2026
Coverage healthy
Theme aheadTheme behindNifty 500Base 100 at the first visible weekLatest: Outperforming +4.4%
949810210711130 Apr 2026 | Healthcare & Hospitals 100.0 | Nifty 500 100.0 | In line 0.0% | breadth 56% | coverage 99%08 May 2026 | Healthcare & Hospitals 104.0 | Nifty 500 101.9 | Outperforming +2.1% | breadth 77% | coverage 99%15 May 2026 | Healthcare & Hospitals 100.9 | Nifty 500 99.3 | Outperforming +1.6% | breadth 26% | coverage 99%22 May 2026 | Healthcare & Hospitals 101.0 | Nifty 500 99.9 | Outperforming +1.1% | breadth 49% | coverage 99%29 May 2026 | Healthcare & Hospitals 101.8 | Nifty 500 99.9 | Outperforming +1.9% | breadth 53% | coverage 99%05 Jun 2026 | Healthcare & Hospitals 101.5 | Nifty 500 99.0 | Outperforming +2.5% | breadth 45% | coverage 99%12 Jun 2026 | Healthcare & Hospitals 101.5 | Nifty 500 99.6 | Outperforming +1.9% | breadth 46% | coverage 99%19 Jun 2026 | Healthcare & Hospitals 103.3 | Nifty 500 102.1 | Outperforming +1.2% | breadth 61% | coverage 99%26 Jun 2026 | Healthcare & Hospitals 103.7 | Nifty 500 101.9 | Outperforming +1.8% | breadth 48% | coverage 98%03 Jul 2026 | Healthcare & Hospitals 105.6 | Nifty 500 102.7 | Outperforming +2.8% | breadth 65% | coverage 99%10 Jul 2026 | Healthcare & Hospitals 105.2 | Nifty 500 103.0 | Outperforming +2.1% | breadth 44% | coverage 99%17 Jul 2026 | Healthcare & Hospitals 104.7 | Nifty 500 102.9 | Outperforming +1.7% | breadth 39% | coverage 99%24 Jul 2026 | Healthcare & Hospitals 103.5 | Nifty 500 101.1 | Outperforming +2.4% | breadth 33% | coverage 99%31 Jul 2026 | Healthcare & Hospitals 104.6 | Nifty 500 103.4 | Outperforming +1.2% | breadth 58% | coverage 98%07 Aug 2026 | Healthcare & Hospitals 106.9 | Nifty 500 104.5 | Outperforming +2.3% | breadth 63% | coverage 99%14 Aug 2026 | Healthcare & Hospitals 107.0 | Nifty 500 104.0 | Outperforming +2.9% | breadth 42% | coverage 99%21 Aug 2026 | Healthcare & Hospitals 108.0 | Nifty 500 103.6 | Outperforming +4.2% | breadth 49% | coverage 99%28 Aug 2026 | Healthcare & Hospitals 108.8 | Nifty 500 103.7 | Outperforming +4.9% | breadth 51% | coverage 99%04 Sept 2026 | Healthcare & Hospitals 108.9 | Nifty 500 102.5 | Outperforming +6.2% | breadth 45% | coverage 99%11 Sept 2026 | Healthcare & Hospitals 109.0 | Nifty 500 100.8 | Outperforming +8.1% | breadth 42% | coverage 99%18 Sept 2026 | Healthcare & Hospitals 108.1 | Nifty 500 100.7 | Outperforming +7.3% | breadth 41% | coverage 99%25 Sept 2026 | Healthcare & Hospitals 109.0 | Nifty 500 99.6 | Outperforming +9.4% | breadth 49% | coverage 99%01 Oct 2026 | Healthcare & Hospitals 105.6 | Nifty 500 96.4 | Outperforming +9.5% | breadth 17% | coverage 100%09 Oct 2026 | Healthcare & Hospitals 103.7 | Nifty 500 96.4 | Outperforming +7.6% | breadth 30% | coverage 99%16 Oct 2026 | Healthcare & Hospitals 103.7 | Nifty 500 98.2 | Outperforming +5.6% | breadth 46% | coverage 98%22 Oct 2026 | Healthcare & Hospitals 99.8 | Nifty 500 95.6 | Outperforming +4.4% | breadth 11% | coverage 98%Outperforming +4.4%30 Apr 202624 Jul 202622 Oct 2026
Theme return · 26W
-0.2%
Nifty 500 · 26W
-4.4%
Vs Nifty 500 · 26W
+4.4%
Latest coverage
333/340
How this plot is calculated

The theme line is green when its cumulative rebased performance is above Nifty 500 and red when it is below. The chart callout shows the latest relative performance as the theme level divided by the benchmark level, minus one.

The basket uses the theme's current reviewed companies. For each available week, we calculate every valid constituent's close-to-close return and give each company the same weight. If a weekly rollup is missing or lags the daily series, the final available daily close in that week is used; the last point can therefore be week-to-date.

For baskets with at least 10 valid stocks, the highest and lowest 5% of weekly returns are trimmed to reduce split, corporate-action, and single-stock distortions. Weekly basket returns are then compounded and rebased to 100 beside the Nifty 500.

Breadth is the share of valid constituents that rose that week. Coverage is the number with usable aligned prices divided by current membership. Weekly moves above 80% are excluded as likely data or corporate-action outliers.

Limitation: this is a current-membership historical reconstruction, not a point-in-time investable index. It can contain survivorship bias and excludes costs, liquidity impact, dividends, and rebalancing turnover.

Model note: Current-member weekly equal-weight returns (5% tails trimmed for baskets of 10+), compounded and rebased to 100 against Nifty 500. Rotation is anchored at 100 = Nifty 500 parity: the horizontal axis is 13-week excess return and the vertical axis is its four-week acceleration. Lagging weekly rollups are patched with the final available daily close, so the latest observation may be week-to-date.

Theme scorecard

Measures whether this idea is investable today by blending cohort quality, valuation cushion, and price momentum. It is a research filter, not advice.

Build portfolio from this theme
Theme
30
Stretched
Quality
18
Valuation
35
Momentum
51
Positive MoS
44%
P/E 59.8 · ROCE 14%
Curated research view

Healthcare & Hospitals

A focused investor view: high-conviction names first, then small/micro exposure only as controlled satellite risk. Live U-Score and MoS still come from the current database.

74/100
Theme score
High Conviction
Investability
40.5
Live avg U
-1061.6%
Live avg MoS

Curated company map

Names from the curated theme note. Solid chips are present in the live eligible cohort; dashed chips need membership review, ticker verification, or may be indirect/unlisted exposure.

11/11 live eligible

Investment thesis

Rising healthcare spend, insurance penetration, medical tourism, elective procedures, diagnostics, and specialty hospitals create a long growth runway.

1-2 year outlook: Very positive. Hospital chains and diagnostics can compound if occupancy, ARPOB, and margins improve.
Recommended allocation: 8-12%.

Key triggers

  • Elective surgery growth
  • Health insurance expansion
  • Medical tourism recovery
  • Diagnostics and preventive testing

Major risks

  • High valuations
  • Pricing regulation
  • Metro competition
  • Debt in expansion phase
Small, micro, and SME names should be opt-in exposure. Suggested filters: U-Score above 65, positive MoS, Piotroski 7+, debt/equity below 0.8, promoter pledge below 10%, and enough traded value to exit without slippage.

Thesis

A data-generated Healthcare basket from tagged stocks. It focuses on occupancy, ARPOB, diagnostics, and insurance penetration.

  • ▸Healthcare spend
  • ▸Insurance penetration
  • ▸Pricing regulation risk

Top picks · ranked by U-Score within this cohort

Full cohort

ARISTOSME
Aristo Bio-Tech and Lifescience Ltd.
Pharma
DEEP VALUE

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +81.2%Piotroski: 7/9ROCE: 20%P/E: 8.5D/E: 0.80
77
U-Score
₹89.30
Open →
UGARSUGARSmall
The Ugar Sugar Works Limited
Consumer
DEEP VALUE

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +74.6%Piotroski: 7/9ROCE: 27%P/E: 9.7D/E: 1.31
76
U-Score
₹51.52
Open →
ZENITHDRUGSME
Zenith Drugs Ltd.
Pharma
DEEP VALUE

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +84.8%Piotroski: 6/9ROCE: 27%P/E: 6.9D/E: 0.40
75
U-Score
₹38.20
Open →
INDRAMEDCOSmall
Indraprastha Medical Corporation Limited
Pharma
DEEP VALUE

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +66.4%Piotroski: 8/9ROCE: 36%P/E: 15.6D/E: 0.05
75
U-Score
₹310.10
Open →
JSLLMicro
Jeena Sikho Lifecare Limited
Consumer
DEEP VALUE

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +42.7%Piotroski: 8/9ROCE: 64%P/E: 20.4D/E: 0.27
75
U-Score
₹363.35
Open →
MAFATINDSmall
Mafatlal Industries Limited
Consumer
UNDERVALUED

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +59.0%Piotroski: 7/9ROCE: 13%P/E: 13.2D/E: 0.08
74
U-Score
₹111.47
Open →
REFEXMicro
Refex Industries Limited
Chemicals
UNDERVALUED

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +70.6%Piotroski: 8/9ROCE: 23%P/E: 11.5D/E: 0.15
73
U-Score
₹239.15
Open →
NATCOPHARMSmall
Natco Pharma Limited
Pharma
UNDERVALUED

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +70.1%Piotroski: 8/9ROCE: 17%P/E: 13.7D/E: 0.08
73
U-Score
₹784.45
Open →
SATKARTARSME
Sat Kartar Shopping Ltd.
Pharma
UNDERVALUED

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +73.2%Piotroski: 6/9ROCE: 36%P/E: 18.1D/E: 0.03
72
U-Score
₹131.15
Open →
TEMBOSmall
Tembo Global Industries Limited
Consumer
UNDERVALUED

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +72.2%Piotroski: 6/9ROCE: 23%P/E: 10.0D/E: 0.85
71
U-Score
₹53.13
Open →
QUESTLABSME
Quest Laboratories Ltd.
Pharma
UNDERVALUED

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +77.9%Piotroski: 6/9ROCE: 18%P/E: 11.3D/E: 0.08
70
U-Score
₹90.20
Open →
MONTECARLOSmall
Monte Carlo Fashions Limited
Consumer
UNDERVALUED

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +74.5%Piotroski: 8/9ROCE: 14%P/E: 10.2D/E: 0.64
70
U-Score
₹515.30
Open →
GPTHEALTHSmall
GPT Healthcare Limited
Pharma
UNDERVALUED

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +42.2%Piotroski: 8/9ROCE: 24%P/E: 29.5D/E: 0.61
70
U-Score
₹135.68
Open →
MEDISTEPSME
Medistep Healthcare Ltd.
Pharma
UNDERVALUED

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +88.7%Piotroski: 6/9ROCE: 27%P/E: 5.1D/E: 0.14
69
U-Score
₹21.40
Open →
JFLLIFESME
JFL Life Sciences Ltd.
Pharma
UNDERVALUED

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +88.3%Piotroski: 6/9ROCE: 18%P/E: 5.0D/E: 0.48
69
U-Score
₹10.80
Open →
WANBURYSmall
Wanbury Limited
Pharma
UNDERVALUED

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +74.0%Piotroski: 7/9ROCE: 31%P/E: 11.2D/E: 1.56
69
U-Score
₹187.67
Open →
STARMicro
Strides Pharma Science Limited
Pharma
UNDERVALUED

Auto-included from the Healthcare tag. Use the scorecard and metrics to decide whether it fits your thesis.

MoS: +65.6%Piotroski: 8/9ROCE: 18%P/E: 16.6D/E: 0.57
69
U-Score
₹1029.30
Open →
Sign in for the full theme cohort

The first 20 ranked names are open. Sign in to see every company attached to this theme. 320 more rows available after sign-in.

Sign in
The rationale above is editorial — the ranking uses our U-Score engine so the names you see first are the strongest fundamentals fit, not the most popular or most-mentioned. Re-rank yourself if you weigh valuation or quality differently. All information is for study purposes only — consult your financial advisor before investing.